Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients | Zendy

John L. Sapp | Zendy; Ratika Parkash | Zendy; George A. Wells | Zendy; Elizabeth Yetisir | Zendy; Martin J. Gardner | Zendy; Jeff S. Healey | Zendy; Bernard Thibault | Zendy; Laurence D. Sterns | Zendy; David H. Birnie | Zendy; Pablo B. Nery | Zendy; Soori Sivakumaran | Zendy; Vidal Essebag | Zendy; Paul Dorian | Zendy; Anthony Tang | Zendy

Open Access

Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients

Author(s) -

John L. Sapp,

Ratika Parkash,

George A. Wells,

Elizabeth Yetisir,

Martin J. Gardner,

Jeff S. Healey,

Bernard Thibault,

Laurence D. Sterns,

David H. Birnie,

Pablo B. Nery,

Soori Sivakumaran,

Vidal Essebag,

Paul Dorian,

Anthony Tang

Publication year - 2017

Publication title -

circulation arrhythmia and electrophysiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.684

H-Index - 102

eISSN - 1941-3149

pISSN - 1941-3084

DOI - 10.1161/circep.116.004875

Subject(s) - medicine , implantable cardioverter defibrillator , cardiac resynchronization therapy , cardiology , heart failure , ventricular fibrillation , secondary prevention , ejection fraction

The RAFT (Resynchronization in Ambulatory Heart Failure Trial) demonstrated that cardiac resynchronization therapy (CRT) reduced both mortality and heart failure hospitalizations in patients with functional class II or III heart failure and widened QRS. We examined the influence of CRT on ventricular arrhythmias in patients with primary versus secondary prophylaxis defibrillator indications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research